By: Blanco S.B. No. 2212

(In the Senate - Filed March 9, 2023; March 22, 2023, read first time and referred to Committee on Health & Human Services; April 25, 2023, reported adversely, with favorable Committee Substitute by the following vote: Yeas 6, Nays 0; April 25, 2023, sent to printer.) Click here to see the committee vote

COMMITTEE SUBSTITUTE FOR S.B. No. 2212 By: Kolkhorst

A BILL TO BE ENTITLED

AN ACT

relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Section 562.003, Occupations Code, is amended to read as follows:

Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A pharmacy shall disclose the lowest cost cash price at that pharmacy for the drug or biological product prescribed to the patient.

(b) If the price of a drug or biological product to a patient is lower than the amount of the patient's copayment under the patient's prescription drug insurance plan, the pharmacist shall offer the patient the option of paying for the drug or biological product at the lower price instead of paying the amount of the copayment.

SECTION 2. This Act takes effect September 1, 2023.

* * * * *